[
  {
    "ts": null,
    "headline": "Hotchkis & Wiley Global Value Fund Q4 2024 Commentary",
    "summary": "The Hotchkis & Wiley Global Value Fund outperformed the MSCI World Value Index in the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=ea568b5ecdfe597de2798fbc7dd2b10372d1cf1ad2eb106eea31dfebcfae19b6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740544200,
      "headline": "Hotchkis & Wiley Global Value Fund Q4 2024 Commentary",
      "id": 132876630,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/96502248/image_96502248.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The Hotchkis & Wiley Global Value Fund outperformed the MSCI World Value Index in the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=ea568b5ecdfe597de2798fbc7dd2b10372d1cf1ad2eb106eea31dfebcfae19b6"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)",
    "summary": "CVS Health faces operational challenges with earnings misses, rising costs, and regulatory pressures. See why we downgrade CVS stock to a hold.",
    "url": "https://finnhub.io/api/news?id=5e66c168281972b1ea4d165fe251d9db74d04b24e7cdf6e759ea35e00832515b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740542711,
      "headline": "CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)",
      "id": 132876534,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1142092741/image_1142092741.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "CVS Health faces operational challenges with earnings misses, rising costs, and regulatory pressures. See why we downgrade CVS stock to a hold.",
      "url": "https://finnhub.io/api/news?id=5e66c168281972b1ea4d165fe251d9db74d04b24e7cdf6e759ea35e00832515b"
    }
  },
  {
    "ts": null,
    "headline": "Hotchkis & Wiley Value Opportunities Fund Q4 2024 Commentary",
    "summary": "The Hotchkis & Wiley Value Opportunities Fund outperformed the Russell 3000 Value Index in the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=de1e6446bb1a840f1e0ade721e84e9bac342382a4384e5401638fecdabcfb10a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740538800,
      "headline": "Hotchkis & Wiley Value Opportunities Fund Q4 2024 Commentary",
      "id": 132876221,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1628675510/image_1628675510.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The Hotchkis & Wiley Value Opportunities Fund outperformed the Russell 3000 Value Index in the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=de1e6446bb1a840f1e0ade721e84e9bac342382a4384e5401638fecdabcfb10a"
    }
  }
]